Isotretinoin; A review on the Utilization Pattern in Pregnancy

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Khiali Sajad; GHAREKHANI AFSHIN; ENTEZARI MALEKI TAHER

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Advanced Pharmaceutical Bulletin Year:2018 | Volume:8 | Issue:3 Page(s): 377-382

Download Full-Text

View:

160

Download:

103

Cites:

Information Journal Paper

Title

Isotretinoin; A review on the Utilization Pattern in Pregnancy

Author(s)

Khiali Sajad | GHAREKHANI AFSHIN | ENTEZARI MALEKI TAHER | Issue Writer Certificate

Keywords

Isotretinoin

Acne

Utilization pattern

Teratogenic effects

Pregnancy

Abstract

Purpose: Isotretinoin is the most effective anti-Acne drug with a long-term remission. However; it contains severe Teratogenic effects with serious adverse drug reactions, which limits the use of medication. Methods: To review the use of Isotretinoin during Pregnancy, we carried out a comprehensive search of literature in Google Scholar, Scopus and PubMed/Medline from their inception until April 2015. Results: Database searching identified 277 records, of which, 38 articles were retrieved according to abstract and title assessment. After full-text review, 17 articles were excluded and finally, a total of 21 studies met the inclusion criteria. Data showed an increased pattern in the use of Isotretinoin. In some studies, health care providers were not fully adhered to the risk reduction programs in Pregnancy. Exposing to Isotretinoin among pregnant women has still occurred due to detrimental adherence to risk reduction programs which resulted in live-born infants with different kinds of abnormalities. Conclusion: Despite the known serious adverse effect of Isotretinoin, the use of drug was not based on the guidelines in some cases, which needs more attentions to prevent the severe drug related problems.

Cites

No record.

References

No record.

Cite

APA: Copy

Khiali, Sajad, GHAREKHANI, AFSHIN, & ENTEZARI MALEKI, TAHER. (2018). Isotretinoin; A review on the Utilization Pattern in Pregnancy. ADVANCED PHARMACEUTICAL BULLETIN, 8(3), 377-382. SID. https://sid.ir/paper/745474/en

Vancouver: Copy

Khiali Sajad, GHAREKHANI AFSHIN, ENTEZARI MALEKI TAHER. Isotretinoin; A review on the Utilization Pattern in Pregnancy. ADVANCED PHARMACEUTICAL BULLETIN[Internet]. 2018;8(3):377-382. Available from: https://sid.ir/paper/745474/en

IEEE: Copy

Sajad Khiali, AFSHIN GHAREKHANI, and TAHER ENTEZARI MALEKI, “Isotretinoin; A review on the Utilization Pattern in Pregnancy,” ADVANCED PHARMACEUTICAL BULLETIN, vol. 8, no. 3, pp. 377–382, 2018, [Online]. Available: https://sid.ir/paper/745474/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops